Pharma Journalist - Page 918 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Eleven Biotherapeutics Completes Exclusive Licensing Deal for IL-6 Antagonist Antibody Technology

Genmab Enters Commercial License Agreement with Gilead for DuoBody Technology

Sharp Packaging Services Selects TraceLink To Achieve DSCSA Compliance For 100+ Pharmaceutical Manufacturers

Lantern Pharma Announces Transaction to Evaluate BioNumerik’s Tavocept

DNAtrix Awarded FDA Orphan Products Development Grant for DNX-2401

Pluristem Therapeutics Deploys Medidata’s Cloud Technology

Allergan sells global generics business to Teva Pharmaceuticals

Ligand Announces Multi-Program LTP Technology Licensing Agreement with Nucorion Pharmaceuticals

DNAtrix Receives European Medicines Agency PRIME Designation

Synaffix achieves improved therapeutic index compared to both FDA-approved ADCs